Cargando…
RNA Editing: A New Therapeutic Target in Amyotrophic Lateral Sclerosis and Other Neurological Diseases
The conversion of adenosine to inosine in RNA editing (A-to-I RNA editing) is recognized as a critical post-transcriptional modification of RNA by adenosine deaminases acting on RNAs (ADARs). A-to-I RNA editing occurs predominantly in mammalian and human central nervous systems and can alter the fun...
Autores principales: | Hosaka, Takashi, Tsuji, Hiroshi, Kwak, Shin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536083/ https://www.ncbi.nlm.nih.gov/pubmed/34681616 http://dx.doi.org/10.3390/ijms222010958 |
Ejemplares similares
-
Roles of Aging, Circular RNAs, and RNA Editing in the Pathogenesis of Amyotrophic Lateral Sclerosis: Potential Biomarkers and Therapeutic Targets
por: Hosaka, Takashi, et al.
Publicado: (2023) -
Extracellular RNAs as Biomarkers of Sporadic Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases
por: Hosaka, Takashi, et al.
Publicado: (2019) -
Novel therapeutic targets for amyotrophic lateral sclerosis
por: Batra, Gitika, et al.
Publicado: (2019) -
RNA-Targeted Therapies and Amyotrophic Lateral Sclerosis
por: Mathis, Stéphane, et al.
Publicado: (2018) -
Amyotrophic Lateral Sclerosis and Autophagy: Dysfunction and Therapeutic Targeting
por: Amin, Azin, et al.
Publicado: (2020)